Biochemistry, Genetics and Molecular Biology
Genetics
70%
Turner Syndrome
63%
MicroRNA
61%
Circulating Tumor DNA
56%
Klinefelter Syndrome
55%
Gene Expression
46%
Cancer Cell
40%
Methylation
40%
RNA
37%
Genome-Wide Association Study
33%
DNA Methylation
32%
Germline
31%
Germ Cell
31%
Promoter Region
30%
Next Generation Sequencing
29%
Single-Nucleotide Polymorphism
28%
Messenger RNA
27%
RNA Sequence
26%
Transcriptomics
25%
Genetic Divergence
24%
Allele
24%
Transcriptome
22%
Whole Genome Sequencing
22%
Prevalence
22%
Genotyping
22%
Epigenetics
22%
Single Nucleotide Polymorphism
21%
Gene Expression Profiling
20%
Sex Chromosome
20%
Body Composition
19%
Mutation Rate
19%
Oncogene
18%
Exome Sequencing
18%
Marfan's Syndrome
18%
Microarrays
18%
Circular RNA
18%
Cohort Study
17%
Skeletal Muscle
17%
Carcinogenesis
15%
Overall Survival
14%
Human Genome
14%
Insulin Sensitivity
13%
Prostate-Specific Antigen
13%
Mosaicism
13%
Genetic Risk
13%
Proteomics
13%
Insulin Resistance
12%
Genomics
12%
Growth Hormone
12%
Bovine Somatotropin
12%
Exon
12%
Progression Free Survival
12%
T Cell
12%
Transcription Factors
11%
Immune Response
11%
Transfection
11%
Dynamics
11%
Mouse
11%
Cancer Staging
11%
X Chromosome
11%
Chromosome Instability
11%
Gene Mutation
11%
Indel
11%
Clinical Trial
11%
Microsatellite DNA
11%
Somatic Mutation
11%
Genetic Screening
10%
Real-Time Polymerase Chain Reaction
10%
Polymerase Chain Reaction
10%
Chromosome Abnormality
10%
Colon
10%
APOBEC
10%
Recurrence Free Survival
10%
Binding Site
10%
Signal Transduction
9%
Proteome
9%
DNA Analysis
9%
Metabolic Pathway
9%
Sex Difference
9%
CRISPR/Cas9
9%
Exome
9%
Lipid
9%
Microsatellite Instability
9%
BRCA2
9%
Biomarker Discovery
8%
Mendelian Randomization
8%
Cytogenetics
8%
Tumor Marker
8%
Y Chromosome
8%
Epigenomics
8%
Phylogeny
8%
Codon
8%
RNA Sequencing
8%
FBN1
8%
Urine Sampling
8%
Stem Cell
8%
Wild Type
8%
Population
8%
Tumor Gene
8%
Progeny
8%
Medicine and Dentistry
Prostate Cancer
100%
Neoplasm
87%
Turner Syndrome
85%
Circulating Tumor DNA
69%
Malignant Neoplasm
64%
Bladder Cancer
61%
Disease
59%
Biological Marker
52%
Recurrent Disease
44%
Colorectal Cancer
36%
Non Muscle Invasive Bladder Cancer
34%
microRNA
29%
Diagnosis
27%
Prostatectomy
27%
Transitional Cell Carcinoma
26%
Bladder Tumor
24%
Klinefelter Syndrome
24%
Cell-Free DNA
24%
Cohort Analysis
22%
Biochemical Recurrence
21%
Breast Cancer
21%
Hazard Ratio
21%
Metastatic Carcinoma
20%
Cancer Risk
20%
Biopsy
18%
Muscle Invasive Bladder Cancer
17%
Risk Stratification
17%
Methylation
16%
DNA Methylation
16%
Mendelian Randomization Analysis
14%
Sex Hormone
13%
Primary Tumor
13%
Gene Expression
13%
Prostate Specific Antigen
13%
Hormone Substitution
13%
Next Generation Sequencing
13%
Maturity Onset Diabetes of the Young
12%
Single Nucleotide Polymorphism
12%
Prevalence
12%
Cystoscopy
12%
Immunotherapy
12%
Diethylstilbestrol
12%
Positron Emission Tomography-Computed Tomography
11%
DNA Determination
11%
Insulin Dependent Diabetes Mellitus
11%
Cystectomy
10%
Cardiovascular Disease
10%
Recurrence Risk
10%
Proportional Hazards Model
10%
Placebo
10%
Genome Wide Association Study
9%
Clinical Trial
9%
Skeletal Muscle
9%
Prostate Specific Membrane Antigen
9%
Gallium 68
9%
Marfan Syndrome
9%
Minimal Residual Disease
9%
Transcriptomics
9%
Growth Hormone
9%
Somatics
9%
Fibroblast Growth Factor Receptor 3
9%
Urinary System
9%
Systematic Review
9%
Treatment Response
9%
Substitution Therapy
8%
Disorders of Sex Development
8%
Meta-Analysis
8%
Cancer Staging
8%
Gene Expression Profiling
8%
Insulin Sensitivity
8%
Genetic Risk
8%
Adipose Tissue
8%
Lifespan
8%
47,XYY Syndrome
8%
Infection
8%
Mycosis fungoides
7%
Neoadjuvant Chemotherapy
7%
Surgery
7%
Cancer Cell
7%
Adjuvant Therapy
7%
Drug Therapy
7%
Immune Response
7%
Sex Chromosome Aberration
7%
Sex Chromosome
7%
RNA Sequence
7%
Cytokine
7%
Overall Survival
7%
Child
7%
Congenital Malformation
7%
Cancer Types
7%
Bladder
7%
Magnetic Resonance Imaging
7%
Clear Cell Renal Cell Carcinoma
7%
Lymph Node Metastasis
7%
Adjuvant Chemotherapy
6%
Colorectal Carcinoma
6%
BRCA2
6%
Liquid Biopsy
6%
Odds Ratio
6%
Blood Pressure
6%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
59%
Malignant Neoplasm
44%
Prostate Cancer
41%
Circulating Tumor DNA
39%
Turner Syndrome
39%
Bladder Cancer
38%
Recurrent Disease
35%
Biological Marker
31%
Disease
29%
Colorectal Cancer
21%
Non Muscle Invasive Bladder Cancer
20%
Replacement Therapy
15%
Biochemical Recurrence
14%
Bladder Tumor
14%
Insulin Dependent Diabetes Mellitus
14%
Marfan Syndrome
13%
Klinefelter Syndrome
13%
Placebo
13%
Diethylstilbestrol
13%
Cohort Study
13%
Chemotherapy
12%
Growth Hormone
11%
microRNA
11%
Muscle Invasive Bladder Cancer
11%
Mouse
10%
Prevalence
9%
Metastatic Colorectal Cancer
9%
Androgen
8%
Sex Hormone
8%
Fibroblast Growth Factor Receptor 3
8%
Progression Free Survival
8%
Transitional Cell Carcinoma
8%
Overall Survival
8%
Clinical Trial
6%
Disease Exacerbation
6%
Immunotherapy
6%
Tumor Necrosis Factor
6%
Transdermal
6%
Cancer Staging
6%
Minimal Residual Disease
5%
5 Hydroxymethylcytosine
5%
Protein P53
5%
Carcinogenesis
5%
Tumor Suppressor Protein
5%
Insulin Resistance
5%
Diseases
5%